To compare the efficacy and safety of nifedipine sustained release with Ginkgo biloba extract to treat patients with primary Raynaud's phenomenon in South Korea; Korean Raynaud study (KOARA study)

Choi WS, Choi CJ, Kim KS

Published in Clinical Rheumatology, Vol. 28 (5), pp. 553-9

Methodology

Randomised open comparison of Ginkgo biloba extract with nifedipine over 8 weeks in primary Raynaud phenomenon.

Both treatments reduced attack frequency, with nifedipine producing a greater reduction than Ginkgo biloba.

Ginkgo is inferior to standard vasodilator therapy for cold-induced attacks.

Small, unblinded, no placebo arm.

Herb

Both treatments reduced attack frequency, with nifedipine producing a greater reduction than Ginkgo biloba.

Year:2009

Sample Size:40

Quality Score:6/10

This information is for educational purposes only. Always consult a healthcare professional before starting any supplement regimen.